ORTHOFIX MEDICAL INC.

OFIX Healthcare Medical Devices

ORTHOFIX MEDICAL INC.’s revenue for fiscal 2025 (year ended December 2025) was $822.3 million, up 2.85% from fiscal 2024. In the quarter to June 2026, revenue grew 3.85%, EPS fell 8.33%, free cash flow fell 516.6% and total debt rose 34.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

9.38 0.21 −2.19%
Market cap
$390.6M
P/E
0.0×
Fwd P/E
−8.5×
Dividend yield
—
F-score
5/9
Altman Z
1.29
Beneish M
−3.19
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
0.71 0.73 0.56 0.45
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
46.94 21.68 (26.35) (60.07)
P/B ratio
1.32 1.33 1.07 0.87
EV/Sales
0.85 0.85 0.71 0.61
EV/EBITDA
135.49 380.93 38.57 26.35
EV/FCF
(133.74) (193.86) (86.67) (16.93)
Current Ratio
2.47 2.45 2.87 2.84
Net Debt/EBITDA
(43.01) 5.75 986.10 20.89
Debt/Equity
0.39 0.39 0.54 0.55
Earnings Yield
(20.70%) (15.44%) (13.16%) (16.85%)
Free Cash Flow Yield
(0.90%) (0.60%) (1.45%) (8.06%)
Free Cash Flow per Share
0.06 0.42 (0.70) (0.46)
Book value per Share
11.13 11.36 10.76 10.49
Free Cash Flow
2.50 16.82 (28.27) (18.87)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates